Presentation is loading. Please wait.

Presentation is loading. Please wait.

Heart Failure. Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure.

Similar presentations


Presentation on theme: "Heart Failure. Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure."— Presentation transcript:

1 Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure

2 Heart Failure

3 Traditional Treatment for Acute Decompensated Heart Failure

4 Traditional Treatment for Acute Decompensated Heart Failure (cont)

5 Traditional Treatment for Acute Decompensated Heart Failure (cont)

6 Traditional Positive Inotropic Agents

7 Omecamtiv Mecarbil: A Novel Selective Cardiac Myosin Activator

8 Omecamtiv Mecarbil

9 Omecamtiv Mecarbil: Echocardiogram Changes in Healthy Volunteers

10 Omecamtiv Mecarbil: Echocardiographic Changes in Patients With Stable Heart Failure and LV Dysfunction

11 ATOMIC-AHF: Study Design Randomized, Double-blind, Placebo-controlled, Sequential Cohort Study

12 ATOMIC-AHF-Primary End Point: Dyspnea Response Paired Placebo

13 Safety Concerns

14 Supraventricular and Ventricular Tachyarrhythmias

15 COSMIC-HF: Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure

16 References

17 Abbreviations

18 Abbreviations (cont)


Download ppt "Heart Failure. Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure."

Similar presentations


Ads by Google